Is your company considering a tender offer? Here's what you should know. Private companies often operate under the assumption employees will wait years—sometimes up to a decade—for an initial public ...
Transcripts are generated using a combination of speech recognition software and human transcribers, and may contain errors. Please check the corresponding audio for the authoritative record. Lynne ...
JACKSONVILLE, Fla.--(BUSINESS WIRE)--Rayonier Advanced Materials Inc. (NYSE: RYAM) (the “Company” or “RYAM”), the global leader in High Purity Cellulose, and ...
Compelling and certain value of $265 per share in cash, unanimously recommended by the independent AspenTech Special Committee, represents Emerson's best and final price Emerson is a disciplined ...
WOONSOCKET, R.I., Dec. 9, 2024 /PRNewswire/ -- CVS Health Corporation ("CVS Health", NYSE: CVS) announced today the results of the previously announced cash tender offer (the "Any and All Tender Offer ...
You open your inbox and there it is: “Company Tender Offer—Action Required.” It sounds official (because it is), but also a little opaque. You’ve worked for years for those options or RSUs. Is this ...
The abrdn Emerging Markets Equity Income Fund is shifting to an "ex-China" strategy, aiming to align with investor sentiment and reduce exposure to Chinese equities. The fund's new policies include a ...
NEW YORK--(BUSINESS WIRE)--BlackRock Advisors, LLC (“BlackRock”) announced today that on October 15, 2024, BlackRock Municipal Income Fund, Inc. (NYSE: MUI, the “Fund”) will commence a tender offer to ...
LEXINGTON, Mass., Oct. 20, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a ...
The MarketWatch News Department was not involved in the creation of this content. NEWCASTLE, NEW SOUTH WALES, Australia, June 9, 2025 /PRNewswire/ -- Newcastle Coal Infrastructure Group Pty Ltd (the ...
REDWOOD CITY, Calif., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company pioneering the use of intravitreal gene therapy as a potential One And ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback